Live News Reader

Some of the articles presented on this website are accessed through RSS feeds from third-party sources that are not necessarily part of the Histiocytosis Association. While we try to select appropriate feeds to prevent objectionable content from being displayed, the presence of any article does not indicate endorsement or recommendation by the Histiocytosis Association.

If you know of a histio-related article that isn't shown here, please send the article to outreach@histio.org.

"Erdheim-Chester disease" - Google News
Lofaro winning battle against rare ECD - Weakley County Press
Lofaro winning battle against rare ECD  Weakley County Press
Thursday, December 19, 2019 7:43:34 AM

2019 ACR/EULAR Classification Criteria for IgG4-Related Disease - Rheumatology Advisor
2019 ACR/EULAR Classification Criteria for IgG4-Related Disease  Rheumatology Advisor
Monday, January 13, 2020 4:00:00 AM

Deciphering telltale symptoms of vasculitis, Erdheim-Chester disease - Healio
Deciphering telltale symptoms of vasculitis, Erdheim-Chester disease  Healio
Wednesday, October 16, 2019 3:00:00 AM

FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer - FDA.gov
FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer  FDA.gov
Monday, November 06, 2017 3:00:00 AM

Genes associated with Erdheim-Chester disease also linked to cancer: New drug treatments to be tested - Science Daily
Genes associated with Erdheim-Chester disease also linked to cancer: New drug treatments to be tested  Science Daily
Friday, March 31, 2017 3:00:00 AM

FDA Approves Vemurafenib for Treating Erdheim-Chester Disease - Cancer Network
FDA Approves Vemurafenib for Treating Erdheim-Chester Disease  Cancer Network
Thursday, November 09, 2017 3:00:00 AM

CNS Abnormalities Common in Erdheim-Chester Disease - Neurology Advisor
CNS Abnormalities Common in Erdheim-Chester Disease  Neurology Advisor
Friday, February 23, 2018 3:00:00 AM

Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis - On Cancer - Memorial Sloan Kettering
Largest Study of Its Kind Reveals New Targetable Genetic Causes of the Rare Blood Disorder Histiocytosis  On Cancer - Memorial Sloan Kettering
Wednesday, December 04, 2019 3:00:00 AM

The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure - Washington Post
The ultra-rare Erdheim-Chester disease: Turning grief into a campaign for a cure  Washington Post
Monday, November 17, 2014 3:00:00 AM

MEK Inhibition Spurs Durable Responses in Patients With Histiocytic Neoplasms - Cancer Therapy Advisor
MEK Inhibition Spurs Durable Responses in Patients With Histiocytic Neoplasms  Cancer Therapy Advisor
Wednesday, March 13, 2019 3:00:00 AM

Share with Others

© Histiocytosis Association, Inc.
332 North Broadway, Pitman, New Jersey  08071 USA
Phone: +1 856-589-6606 | Fax: +1 856-589-6614
| info@histio.org
US & Canada Toll-Free: 1-800-548-2758 
Privacy | DisclaimerState Fundraising Notices 
Tax ID: 22-2827069 | Contact Us 
Follow Me on Pinterest   


¿No Habla Inglés? Si usted puede escribirme sus preguntas y preocupaciones a la dirección de correo electrónico: outreach@histio.org. Nosotros podremos responderle tan pronto nos sea possible. Gracias!